ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ED Treatment Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-25A462
Home | Market Reports | Health| Pharmacy
Global ED Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global ED Treatment Market Research Report 2025

Code: QYRE-Auto-25A462
Report
July 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO

ED Treatment Market Size

The global market for ED Treatment was valued at US$ 5458 million in the year 2024 and is projected to reach a revised size of US$ 8160 million by 2031, growing at a CAGR of 6.0% during the forecast period.

ED Treatment Market

ED Treatment Market

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for ED Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ED Treatment.
The ED Treatment market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ED Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ED Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of ED Treatment Market Report

Report Metric Details
Report Name ED Treatment Market
Accounted market size in year US$ 5458 million
Forecasted market size in 2031 US$ 8160 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Drugstores
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of ED Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of ED Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is ED Treatment Market growing?

Ans: The ED Treatment Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the ED Treatment Market size in 2031?

Ans: The ED Treatment Market size in 2031 will be US$ 8160 million.

Who are the main players in the ED Treatment Market report?

Ans: The main players in the ED Treatment Market are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO.

What are the Application segmentation covered in the ED Treatment Market report?

Ans: The Applications covered in the ED Treatment Market report are Hospitals, Drugstores, Other

What are the Type segmentation covered in the ED Treatment Market report?

Ans: The Types covered in the ED Treatment Market report are Sildenafil, Tadalafil, Others

Recommended Reports

Sexual Health Treatments

Reproductive Health

Urological & Associated Therapies

1 ED Treatment Market Overview
1.1 Product Definition
1.2 ED Treatment by Type
1.2.1 Global ED Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 ED Treatment by Application
1.3.1 Global ED Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Global ED Treatment Market Size Estimates and Forecasts
1.4.1 Global ED Treatment Revenue 2020-2031
1.4.2 Global ED Treatment Sales 2020-2031
1.4.3 Global ED Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 ED Treatment Market Competition by Manufacturers
2.1 Global ED Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global ED Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global ED Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of ED Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ED Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ED Treatment, Product Type & Application
2.7 Global Key Manufacturers of ED Treatment, Date of Enter into This Industry
2.8 Global ED Treatment Market Competitive Situation and Trends
2.8.1 Global ED Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest ED Treatment Players Market Share by Revenue
2.8.3 Global ED Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global ED Treatment Market Scenario by Region
3.1 Global ED Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global ED Treatment Sales by Region: 2020-2031
3.2.1 Global ED Treatment Sales by Region: 2020-2025
3.2.2 Global ED Treatment Sales by Region: 2026-2031
3.3 Global ED Treatment Revenue by Region: 2020-2031
3.3.1 Global ED Treatment Revenue by Region: 2020-2025
3.3.2 Global ED Treatment Revenue by Region: 2026-2031
3.4 North America ED Treatment Market Facts & Figures by Country
3.4.1 North America ED Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America ED Treatment Sales by Country (2020-2031)
3.4.3 North America ED Treatment Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe ED Treatment Market Facts & Figures by Country
3.5.1 Europe ED Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe ED Treatment Sales by Country (2020-2031)
3.5.3 Europe ED Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ED Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific ED Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific ED Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific ED Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America ED Treatment Market Facts & Figures by Country
3.7.1 Latin America ED Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America ED Treatment Sales by Country (2020-2031)
3.7.3 Latin America ED Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa ED Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa ED Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa ED Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa ED Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global ED Treatment Sales by Type (2020-2031)
4.1.1 Global ED Treatment Sales by Type (2020-2025)
4.1.2 Global ED Treatment Sales by Type (2026-2031)
4.1.3 Global ED Treatment Sales Market Share by Type (2020-2031)
4.2 Global ED Treatment Revenue by Type (2020-2031)
4.2.1 Global ED Treatment Revenue by Type (2020-2025)
4.2.2 Global ED Treatment Revenue by Type (2026-2031)
4.2.3 Global ED Treatment Revenue Market Share by Type (2020-2031)
4.3 Global ED Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global ED Treatment Sales by Application (2020-2031)
5.1.1 Global ED Treatment Sales by Application (2020-2025)
5.1.2 Global ED Treatment Sales by Application (2026-2031)
5.1.3 Global ED Treatment Sales Market Share by Application (2020-2031)
5.2 Global ED Treatment Revenue by Application (2020-2031)
5.2.1 Global ED Treatment Revenue by Application (2020-2025)
5.2.2 Global ED Treatment Revenue by Application (2026-2031)
5.2.3 Global ED Treatment Revenue Market Share by Application (2020-2031)
5.3 Global ED Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly ED Treatment Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer ED Treatment Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer ED Treatment Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Company Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BaiYunShan General Factory ED Treatment Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Company Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 S.K. Chemicals ED Treatment Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Company Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharma ED Treatment Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.7.1 Dong-A ST Company Information
6.7.2 Dong-A ST Description and Business Overview
6.7.3 Dong-A ST ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dong-A ST ED Treatment Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Metuchen Pharma
6.8.1 Metuchen Pharma Company Information
6.8.2 Metuchen Pharma Description and Business Overview
6.8.3 Metuchen Pharma ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Metuchen Pharma ED Treatment Product Portfolio
6.8.5 Metuchen Pharma Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Company Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Seoul Pharma ED Treatment Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 CSBIO.
6.10.1 CSBIO. Company Information
6.10.2 CSBIO. Description and Business Overview
6.10.3 CSBIO. ED Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CSBIO. ED Treatment Product Portfolio
6.10.5 CSBIO. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ED Treatment Industry Chain Analysis
7.2 ED Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ED Treatment Production Mode & Process Analysis
7.4 ED Treatment Sales and Marketing
7.4.1 ED Treatment Sales Channels
7.4.2 ED Treatment Distributors
7.5 ED Treatment Customer Analysis
8 ED Treatment Market Dynamics
8.1 ED Treatment Industry Trends
8.2 ED Treatment Market Drivers
8.3 ED Treatment Market Challenges
8.4 ED Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO
List of Tables
 Table 1. Global ED Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global ED Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global ED Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global ED Treatment Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global ED Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global ED Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global ED Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market ED Treatment Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of ED Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of ED Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of ED Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of ED Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global ED Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ED Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global ED Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global ED Treatment Sales by Region (2020-2025) & (Units)
 Table 18. Global ED Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global ED Treatment Sales by Region (2026-2031) & (Units)
 Table 20. Global ED Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global ED Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global ED Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global ED Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global ED Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America ED Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America ED Treatment Sales by Country (2020-2025) & (Units)
 Table 27. North America ED Treatment Sales by Country (2026-2031) & (Units)
 Table 28. North America ED Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America ED Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe ED Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe ED Treatment Sales by Country (2020-2025) & (Units)
 Table 32. Europe ED Treatment Sales by Country (2026-2031) & (Units)
 Table 33. Europe ED Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe ED Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific ED Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific ED Treatment Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific ED Treatment Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific ED Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific ED Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America ED Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America ED Treatment Sales by Country (2020-2025) & (Units)
 Table 42. Latin America ED Treatment Sales by Country (2026-2031) & (Units)
 Table 43. Latin America ED Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America ED Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa ED Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa ED Treatment Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa ED Treatment Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa ED Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa ED Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global ED Treatment Sales (Units) by Type (2020-2025)
 Table 51. Global ED Treatment Sales (Units) by Type (2026-2031)
 Table 52. Global ED Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global ED Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global ED Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global ED Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global ED Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global ED Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global ED Treatment Price (USD/Unit) by Type (2020-2025)
 Table 59. Global ED Treatment Price (USD/Unit) by Type (2026-2031)
 Table 60. Global ED Treatment Sales (Units) by Application (2020-2025)
 Table 61. Global ED Treatment Sales (Units) by Application (2026-2031)
 Table 62. Global ED Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global ED Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global ED Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global ED Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global ED Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global ED Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global ED Treatment Price (USD/Unit) by Application (2020-2025)
 Table 69. Global ED Treatment Price (USD/Unit) by Application (2026-2031)
 Table 70. Eli Lilly Company Information
 Table 71. Eli Lilly Description and Business Overview
 Table 72. Eli Lilly ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Eli Lilly ED Treatment Product
 Table 74. Eli Lilly Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer ED Treatment Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Bayer ED Treatment Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. BaiYunShan General Factory Company Information
 Table 86. BaiYunShan General Factory Description and Business Overview
 Table 87. BaiYunShan General Factory ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. BaiYunShan General Factory ED Treatment Product
 Table 89. BaiYunShan General Factory Recent Developments/Updates
 Table 90. S.K. Chemicals Company Information
 Table 91. S.K. Chemicals Description and Business Overview
 Table 92. S.K. Chemicals ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. S.K. Chemicals ED Treatment Product
 Table 94. S.K. Chemicals Recent Developments/Updates
 Table 95. Teva Pharma Company Information
 Table 96. Teva Pharma Description and Business Overview
 Table 97. Teva Pharma ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Pharma ED Treatment Product
 Table 99. Teva Pharma Recent Developments/Updates
 Table 100. Dong-A ST Company Information
 Table 101. Dong-A ST Description and Business Overview
 Table 102. Dong-A ST ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Dong-A ST ED Treatment Product
 Table 104. Dong-A ST Recent Developments/Updates
 Table 105. Metuchen Pharma Company Information
 Table 106. Metuchen Pharma Description and Business Overview
 Table 107. Metuchen Pharma ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Metuchen Pharma ED Treatment Product
 Table 109. Metuchen Pharma Recent Developments/Updates
 Table 110. Seoul Pharma Company Information
 Table 111. Seoul Pharma Description and Business Overview
 Table 112. Seoul Pharma ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Seoul Pharma ED Treatment Product
 Table 114. Seoul Pharma Recent Developments/Updates
 Table 115. CSBIO. Company Information
 Table 116. CSBIO. Description and Business Overview
 Table 117. CSBIO. ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. CSBIO. ED Treatment Product
 Table 119. CSBIO. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. ED Treatment Distributors List
 Table 123. ED Treatment Customers List
 Table 124. ED Treatment Market Trends
 Table 125. ED Treatment Market Drivers
 Table 126. ED Treatment Market Challenges
 Table 127. ED Treatment Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of ED Treatment
 Figure 2. Global ED Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global ED Treatment Market Share by Type: 2024 & 2031
 Figure 4. Sildenafil Product Picture
 Figure 5. Tadalafil Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global ED Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global ED Treatment Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Drugstores
 Figure 11. Other
 Figure 12. Global ED Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global ED Treatment Market Size (2020-2031) & (US$ Million)
 Figure 14. Global ED Treatment Sales (2020-2031) & (Units)
 Figure 15. Global ED Treatment Average Price (USD/Unit) & (2020-2031)
 Figure 16. ED Treatment Report Years Considered
 Figure 17. ED Treatment Sales Share by Manufacturers in 2024
 Figure 18. Global ED Treatment Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest ED Treatment Players: Market Share by Revenue in ED Treatment in 2024
 Figure 20. ED Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global ED Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America ED Treatment Sales Market Share by Country (2020-2031)
 Figure 23. North America ED Treatment Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe ED Treatment Sales Market Share by Country (2020-2031)
 Figure 27. Europe ED Treatment Revenue Market Share by Country (2020-2031)
 Figure 28. Germany ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific ED Treatment Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific ED Treatment Revenue Market Share by Region (2020-2031)
 Figure 35. China ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America ED Treatment Sales Market Share by Country (2020-2031)
 Figure 46. Latin America ED Treatment Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa ED Treatment Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa ED Treatment Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E ED Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of ED Treatment by Type (2020-2031)
 Figure 56. Global Revenue Market Share of ED Treatment by Type (2020-2031)
 Figure 57. Global ED Treatment Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of ED Treatment by Application (2020-2031)
 Figure 59. Global Revenue Market Share of ED Treatment by Application (2020-2031)
 Figure 60. Global ED Treatment Price (USD/Unit) by Application (2020-2031)
 Figure 61. ED Treatment Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Erectile Dysfunction Market Research Report 2025
Erectile Dysfunction Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Treatment Drugs Market Insights Forecast to 2030
Oral Erectile Dysfunction Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Treatment Market Insights Forecast to 2030
Erectile Dysfunction ED Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Female Sexual Dysfunction Treatment Drug Market Research Report 2024
Global Female Sexual Dysfunction Treatment Market Insights Forecast to 2030
Global Erectile Dysfunction Devices Market Research Report 2024
Sexual Dysfunction Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Penile Implants or Penile Prosthesis Market Research Report 2024
Global Vardenafil Market Insights Forecast to 2030
Erectile Dysfunction ESWT Units Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Erectile Dysfunction Shockwave Therapy Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peyronie s Disease Treatment Market Insights Forecast to 2030
Global Anti erectile Dysfunction ED Drugs Market Insights Forecast to 2030
Global Oral Medications for Erectile Dysfunction Market Research Report 2024
Global Male Hypogonadism Therapy Market Insights Forecast to 2030
Global Erectile Dysfunction Medicine Market Research Report 2024
Global Drugs for Sexual Dysfunction Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions